These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21129930)

  • 1. Biomarkers as a guide for antimicrobial therapy.
    Reinhart K; Hartog CS
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S17-21. PubMed ID: 21129930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin for guidance of antibiotic therapy.
    Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B
    Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL; Van Nuffelen M; Lelubre C
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M; Collins CD
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.
    Christ-Crain M; Müller B
    Eur Respir J; 2007 Sep; 30(3):556-73. PubMed ID: 17766633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin: potential role in diagnosis and management of sepsis.
    Rowland T; Hilliard H; Barlow G
    Adv Clin Chem; 2015; 68():71-86. PubMed ID: 25858869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.
    Schuetz P; Albrich W; Mueller B
    BMC Med; 2011 Sep; 9():107. PubMed ID: 21936959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin elevation suggests a septic source.
    Friend KE; Burgess JN; Britt RC; Collins JN; Weireter LN; Novosel TJ; Britt LD
    Am Surg; 2014 Sep; 80(9):906-9. PubMed ID: 25197879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671].
    Briel M; Christ-Crain M; Young J; Schuetz P; Huber P; Périat P; Bucher HC; Müller B
    BMC Fam Pract; 2005 Aug; 6():34. PubMed ID: 16107222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interpretation of the concentrations of procalcitonin during infectious and inflammatory processes].
    Piatnitskiĭ IA; Sharandak AP; Zokina TG; Berner LP
    Ter Arkh; 2012; 84(12):120-4. PubMed ID: 23480003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procalcitonin--a specific marker for severe bacterial infection and sepsis].
    Elbirt D; Frenkel Rubin M; Ergaz D; Sthoeger Z
    Harefuah; 2001 Apr; 140(4):343-6. PubMed ID: 11303402
    [No Abstract]   [Full Text] [Related]  

  • 16. Procalcitonin-a new marker of severe infection and sepsis.
    Reinhart K; Carlet J
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S145. PubMed ID: 18470708
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?
    Schuetz P; Haubitz S; Mueller B
    Curr Opin Crit Care; 2012 Aug; 18(4):341-9. PubMed ID: 22610364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.
    Heyland DK; Johnson AP; Reynolds SC; Muscedere J
    Crit Care Med; 2011 Jul; 39(7):1792-9. PubMed ID: 21358400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients].
    Robinson JO; Calandra T; Marchetti O
    Rev Med Suisse; 2005 Mar; 1(13):878-82, 885-6. PubMed ID: 15895930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.